Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06941181 · ClinicalTrials.gov registry record · NA

Neurocognitive Predictors of Health Risk Behaviors

A NA study of Substance Use, sponsored by Virginia Polytechnic Institute and State University.

Active
Registry status
NA
Development phase
117
Enrollment target
2
Study locations

NCT06941181 is a NA study of Substance Use that is active but no longer recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 117 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06941181, a NA study of Substance Use, is active but no longer recruiting, sponsored by Virginia Polytechnic Institute and State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
117 participants
Enrollment target
2
Study locations

Study Summary

This study proposes to extend the ongoing longitudinal study of health risk behaviors and obtain new data from former adolescents (followed previously from ages 13-22; Times 1-8) now from ages 23 to 28 (Times 9-11). The goal of this study is to examine the contribution of developing neurocognitive markers to substance use in young adulthood by following a well-characterized longitudinal sample.

Conditions Studied

Interventions

  • OTHER neurocognitive tasks

Study Locations (2)

Virginia

  • Virginia Tech - Blacksburg
  • Fralin Biomedical Research Institute at VTC - Roanoke

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2014-01-20
Est. Completion 2029-05-31
Phase NA

What the Registry Record Tells You About NCT06941181

The ClinicalTrials.gov registry entry for NCT06941181 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (91% lower). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which neurocognitive tasks is the first listed.

NCT06941181 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06941181 about?

NCT06941181 is a clinical study titled "Neurocognitive Predictors of Health Risk Behaviors". This study proposes to extend the ongoing longitudinal study of health risk behaviors and obtain new data from former adolescents (followed previously from ages 13-22; Times 1-8) now from ages 23 to 28 (Times 9-11). The goal of this study is to examine the contribution of developing neurocognitive m...

What is the current status of trial NCT06941181?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2014-01-20. Estimated completion is 2029-05-31.

What conditions does trial NCT06941181 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT06941181?

The interventions under investigation include: neurocognitive tasks (OTHER).

Who is sponsoring clinical trial NCT06941181?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06941181 being conducted?

This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.